A Delobelle-Deroïde

606 total citations
17 papers, 493 citations indexed

About

A Delobelle-Deroïde is a scholar working on Oncology, Surgery and Neurology. According to data from OpenAlex, A Delobelle-Deroïde has authored 17 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Surgery and 3 papers in Neurology. Recurrent topics in A Delobelle-Deroïde's work include Cancer Diagnosis and Treatment (3 papers), Cancer Cells and Metastasis (2 papers) and Breast Cancer Treatment Studies (2 papers). A Delobelle-Deroïde is often cited by papers focused on Cancer Diagnosis and Treatment (3 papers), Cancer Cells and Metastasis (2 papers) and Breast Cancer Treatment Studies (2 papers). A Delobelle-Deroïde collaborates with scholars based in France, Netherlands and Belgium. A Delobelle-Deroïde's co-authors include Christian Duval, A.M. Mandard, P C Clahsen, C. Pallud, Marc J. van de Vijver, C J van de Velde, Lambertus van den Broek, Tarek Sahmoud, Jan Hein van Dierendonck and C.J.H. Van de Velde and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

A Delobelle-Deroïde

16 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Delobelle-Deroïde France 8 317 196 136 78 77 17 493
S A Bartow United States 7 166 0.5× 106 0.5× 88 0.6× 62 0.8× 61 0.8× 8 416
B Höhn Australia 5 163 0.5× 188 1.0× 115 0.8× 170 2.2× 121 1.6× 10 415
Ingirídur Skírnisdóttir Sweden 16 234 0.7× 107 0.5× 176 1.3× 87 1.1× 77 1.0× 26 682
Ivo Marchetti Italy 12 161 0.5× 48 0.2× 125 0.9× 57 0.7× 115 1.5× 20 522
Elizabeth Kornaga Canada 11 255 0.8× 88 0.4× 152 1.1× 27 0.3× 82 1.1× 24 437
Samuel F. Gilbert United States 9 106 0.3× 250 1.3× 161 1.2× 124 1.6× 89 1.2× 14 436
Eline J. C. Nieuwenhuis Netherlands 10 258 0.8× 100 0.5× 184 1.4× 29 0.4× 180 2.3× 11 514
Seden Küçücük Türkiye 11 131 0.4× 116 0.6× 103 0.8× 61 0.8× 26 0.3× 32 322
Yuuji Nakahara Japan 12 278 0.9× 94 0.5× 355 2.6× 27 0.3× 50 0.6× 14 534
C. Bush United Kingdom 10 101 0.3× 191 1.0× 260 1.9× 21 0.3× 77 1.0× 18 484

Countries citing papers authored by A Delobelle-Deroïde

Since Specialization
Citations

This map shows the geographic impact of A Delobelle-Deroïde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Delobelle-Deroïde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Delobelle-Deroïde more than expected).

Fields of papers citing papers by A Delobelle-Deroïde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Delobelle-Deroïde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Delobelle-Deroïde. The network helps show where A Delobelle-Deroïde may publish in the future.

Co-authorship network of co-authors of A Delobelle-Deroïde

This figure shows the co-authorship network connecting the top 25 collaborators of A Delobelle-Deroïde. A scholar is included among the top collaborators of A Delobelle-Deroïde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Delobelle-Deroïde. A Delobelle-Deroïde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Clahsen, P C, C.J.H. Van de Velde, Christian Duval, et al.. (1999). The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices fornode-negative breast cancer. European Journal of Surgical Oncology. 25(4). 356–363. 78 indexed citations
2.
Kann, G., A Delobelle-Deroïde, L Bélair, Arieh Gertler, & Jean Djiane. (1999). Demonstration of in vivo mammogenic and lactogenic effects of recombinant ovine placental lactogen and mammogenic effect of recombinant ovine GH in ewes during artificial induction of lactation. Journal of Endocrinology. 160(3). 365–377. 23 indexed citations
3.
Clahsen, P C, C J van de Velde, Christian Duval, et al.. (1998). p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer.. Journal of Clinical Oncology. 16(2). 470–479. 144 indexed citations
4.
Vilain, M O, A Delobelle-Deroïde, Véronique Cabaret, et al.. (1997). [Immunohistochemical detection of estradiol and progesterone receptors in paraffin sections after treatment with microwaves. Comparison with biochemical assay of receptors in a series of 123 breast cancers with determination of the threshold of optimal positivity].. PubMed. 17(2). 82–8. 4 indexed citations
5.
Lanvin, Dominique, et al.. (1997). Accuracy and Safety of Laparoscopic Lymphadenectomy: An Experimental Prospective Randomized Study. Gynecologic Oncology. 67(1). 83–87. 49 indexed citations
6.
Clahsen, P C, Jan Hein van Dierendonck, Christian Duval, et al.. (1996). Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. British Journal of Cancer. 74(1). 78–85. 104 indexed citations
7.
Clahsen, P C, Jan Hein van Dierendonck, C. Pallud, et al.. (1996). PP-1-6 Expression of BCL-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to peri-operative chemotherapy. European Journal of Cancer. 32. 11–11. 1 indexed citations
8.
Vilain, M O, et al.. (1996). [Pseudomyxoma peritonei secondary to a teratoma of the omentum with a mucinous component of borderline malignancy].. PubMed. 16(3). 182–7. 3 indexed citations
9.
Damotte, Diane, A. Le Tourneau, Josée Audouin, et al.. (1995). Discordant Malignant Lymphoma Synchronous or Successive High-grade B Lymphoma Associated with Hodgkin#X2019:s Disease. Pathology - Research and Practice. 191(1). 8–15. 6 indexed citations
10.
Kauffmann, E., et al.. (1995). [Uterine hemangiopericytomas. Two case reports].. PubMed. 24(2). 149–54.
11.
Cabaret, Véronique, A Delobelle-Deroïde, M O Vilain, & M Lecomte-Houcke. (1994). [Lymphatic metastasis revealing a calcitonin-secreting extrathyroid carcinoma].. PubMed. 14(1). 28–31. 1 indexed citations
12.
Vilain, M O, et al.. (1992). [Stromal luteoma of the ovary. Differential diagnosis of steroid cell tumors].. PubMed. 12(3). 193–7. 2 indexed citations
13.
Cabaret, Véronique, M O Vilain, A Delobelle-Deroïde, & L. Vanseymortier. (1992). [Immunohistochemical demonstration of ceruloplasmin and lactoferrin in a series of 59 thyroid tumors].. PubMed. 12(6). 347–52. 11 indexed citations
14.
Coche‐Dequeant, Bernard, et al.. (1989). [Mobile tongue cancer. Prognostic value of lymph node invasiveness. Apropos of 744 cases].. PubMed. 106(8). 551–5. 1 indexed citations
15.
Lefebvre, J.-L., et al.. (1987). Lymph node invasion in hypopharynx and lateral epilarynx carcinoma: A prognostic factor. Head & Neck Surgery. 10(1). 14–18. 48 indexed citations
16.
Vandewalle, B., J. Savary, M O Vilain, et al.. (1987). Establishment and characterization of a new cell line (VHB-1) derived from a primary breast carcinoma. Journal of Cancer Research and Clinical Oncology. 113(6). 550–558. 16 indexed citations
17.
Warot, P, et al.. (1969). [Extra-dural dorsal angiolipoma: unusual case of medullary compression].. PubMed. 14(3). 311–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S A Bartow Breakdown of academic impact, for papers by B Höhn Breakdown of academic impact, for papers by Ingirídur Skírnisdóttir Breakdown of academic impact, for papers by Ivo Marchetti Breakdown of academic impact, for papers by Elizabeth Kornaga Breakdown of academic impact, for papers by Samuel F. Gilbert Breakdown of academic impact, for papers by Eline J. C. Nieuwenhuis Breakdown of academic impact, for papers by Seden Küçücük Breakdown of academic impact, for papers by Yuuji Nakahara Breakdown of academic impact, for papers by C. Bush
Rankless by CCL
2026